Monday, February 02, 2026 3:01:27 PM
Overview
Novartis CEO Vas Narasimhan talks PhRMA, gene therapy, and ...
The CEO of Novartis is Vasant (Vas) Narasimhan. While his direct email is not publicly listed for general inquiries, corporate communications can often be directed through the Novartis website or general contact channels. Typical email formats for the company include firstname.lastname@novartis.com.
Contact Information
Name: Vas Narasimhan, M.D.
Role: CEO, Novartis
Company Address: Novartis Pharmaceuticals Corporation, 1 Health Plz, East Hanover, NJ 07936, US
Potential Email Structure
Based on company email conventions, the address is likely vas.narasimhan@novartis.com or vasant.narasimhan@novartis.com.
Recent UNCY News
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/10/2026 06:15:05 PM
- Unicycive shares gain as FDA accepts resubmitted OLC NDA • IH Market News • 01/29/2026 03:01:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:14 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/14/2025 10:09:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 02:12:01 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 11:39:29 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/28/2025 11:30:13 AM
- UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit • PR Newswire (US) • 10/14/2025 06:55:00 AM
- Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - UNCY • PR Newswire (US) • 10/02/2025 12:04:00 PM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Unicycive Therapeutics, Inc.(UNCY) Shareholders • PR Newswire (US) • 09/29/2025 12:45:00 PM
- Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – UNCY • Business Wire • 09/25/2025 07:19:00 PM
- The Gross Law Firm Notifies Shareholders of Unicycive Therapeutics, Inc.(UNCY) of a Class Action Lawsuit and an Upcoming Deadline • PR Newswire (US) • 09/25/2025 12:45:00 PM
- Lost Money on Unicycive Therapeutics, Inc.(UNCY)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm • PR Newswire (US) • 09/22/2025 12:45:00 PM
- Shareholders of Unicycive Therapeutics, Inc. Should Contact The Gross Law Firm Before October 14, 2025 to Discuss Your Rights - UNCY • PR Newswire (US) • 09/18/2025 12:45:00 PM
FEATURED Cannabix Technologies Announces First Delivery of Marijuana Breath Test (MBT) to a Major Construction Client • Mar 19, 2026 12:45 PM
ECGI Building in Crypto's Top-Performing Sector as Tokenized Real-World Assets Surge Past $26 Billion • ECGI • Mar 19, 2026 8:30 AM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
